Journal Finds Aussie Breast-Cancer Study Not Influenced By Drug Firm
This article was originally published in PharmAsia News
Executive Summary
Australian drug researcher John Eden has been exonerated of suggestions he may have had a drug maker ghost writer for his study linking progestin with reduced breast-cancer risk